Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention

Metabolically healthy obesity: the low-hanging fruit in obesity treatment?

(2018) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice

(2016) Giulio Marchesini et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Pharmacological management of nonalcoholic fatty liver disease

(2016) Diana Barb et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Phenotypes of prediabetes and stratification of cardiometabolic risk

(2016) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes

(2015) Norbert Stefan et al.   DIABETOLOGIA

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

(2014) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Recent advances in niacin and lipid metabolism

(2013) Vaijinath S. Kamanna et al.   CURRENT OPINION IN LIPIDOLOGY

Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver

(2013) R. Lehmann et al.   DIABETES CARE

Liver fat reduction with niacin is influenced byDGAT-2polymorphisms in hypertriglyceridemic patients

(2012) Miao Hu et al.   JOURNAL OF LIPID RESEARCH

Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue

(2011) Young Taek Oh et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

(2011) Romina Lomonaco et al.   HEPATOLOGY

Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials

(2011) Martina Lukasova et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease

(2010) Elisa Fabbrini et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

(2008) K Kantartzis et al.   GUT

Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL

(2008) Lin-Hua Zhang et al.   JOURNAL OF LIPID RESEARCH